Today: 29 April 2026
Applied Materials stock dips as new U.S. export licenses and China’s 50% tool rule reset focus for AMAT
1 January 2026
2 mins read

Applied Materials stock dips as new U.S. export licenses and China’s 50% tool rule reset focus for AMAT

NEW YORK, January 1, 2026, 14:50 ET — Market closed.

Applied Materials ended the last U.S. session down 1.15% at $256.99, with Wall Street shut on Thursday for the New Year’s Day holiday.

The stock’s next catalyst is not a product launch or an earnings pre-release. It is policy: fresh signals from Washington and Beijing that could change how chipmakers buy — and where they buy — the expensive tools used to make semiconductors.

That matters for Applied because it sells wafer-fab equipment, the specialized machines used to deposit, etch and measure layers on silicon wafers. Small shifts in export rules and local-content mandates can move orders between quarters and between suppliers.

On Tuesday, Reuters reported the U.S. granted Samsung Electronics and SK Hynix annual licenses for 2026 to bring chipmaking equipment into their China facilities, and said a similar annual license was granted to Taiwan Semiconductor Manufacturing Co for its Nanjing site. Reuters said the exemptions known as “validated end user” status — a pre-approval that helped customers receive certain U.S.-origin tools without shipment-by-shipment export licenses — expired on Dec. 31. Reuters+1

Separately, Reuters reported China has told chipmakers seeking state approval to build or expand plants that at least half the equipment used to add new capacity must be domestically made, a requirement the news agency said is not publicly documented and is enforced through procurement tenders. Reuters reported authorities typically reject applications that do not meet the threshold, while also granting flexibility when supply constraints bite and relaxing requirements for advanced production lines where local tools are not yet fully available.

The semiconductor equipment group moved lower into year-end. Lam Research fell 1.52% and KLA dropped 2.29% in Wednesday’s session.

A choppy final trading day left investors debating whether the next leg is driven by chip spending or by the policy backdrop that shapes where that spending lands. “We think the next two years are going to be about the diffusion of AI capabilities throughout the economy,” said Scott Ladner, chief investment officer at Horizon in Charlotte, North Carolina. Reuters

Applied’s shares have now logged two straight daily declines after a seven-session run-up ended on Tuesday, in holiday-thin volume.

For traders, the near-term question is whether annual export licenses become a stable operating framework — or a recurring source of renewal risk — for multinational chipmakers running China fabs. Any shift that slows tool deliveries or changes what can be serviced and upgraded would flow through the order books of U.S. equipment suppliers.

Beijing’s domestic-equipment push adds a second variable. If local-content thresholds steer incremental spending toward Chinese toolmakers on mature-node lines — older manufacturing processes used for many mainstream chips — foreign suppliers may face tougher competition even where their tools remain available.

Before the next U.S. session on Friday, investors will be watching for any follow-on detail from regulators and companies on how the annual-license system will be administered, and whether further U.S.-China measures emerge early in 2026.

Macro events are also back in view as liquidity normalizes after the holiday. The Federal Reserve’s calendar shows its next policy meeting is Jan. 27-28, while the U.S. labor market’s next major read — the Employment Situation report for December 2025 — is scheduled for Jan. 9.

The next company-specific checkpoint is Applied’s earnings. TipRanks lists Applied’s next report date as Feb. 12, after the close. Investors typically focus on management’s demand outlook, order cadence and any commentary on China-related rules that could affect shipments and service activity.

Applied finished Wednesday about 6.92% below its 52-week high of $276.10 reached on Dec. 10, MarketWatch data showed, leaving policy headlines as a key driver until the next hard set of numbers arrives.

Stock Market Today

  • Energean Shifts Investment Outlook with New Angola Deal and Updated Price Targets
    April 29, 2026, 1:31 PM EDT. Energean's central fair value estimate nudged from £9.24 to £9.30, reflecting analyst adjustments amid evolving risks. Berenberg reduced price targets by 75 GBp and 15 GBp, citing concerns over project execution and valuation. Jefferies downgraded Energean in February, signaling caution over its risk-reward balance. Notably, Energean secured the safe restart of its Power FPSO vessel, resuming production after a temporary suspension due to geopolitical tensions in early 2026. The company also agreed to acquire Chevron's interests in offshore Angola blocks for US$260 million plus contingent payments, aiming to boost output and reserves. Investors face execution and valuation risks but gain fresh growth impetus from the Angola acquisition, positioning Energean at a pivotal point for portfolio consideration.

Latest article

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
Gold price forecast for 2026: Banks map a $4,275-$5,000 range after bullion’s blockbuster year
Previous Story

Gold price forecast for 2026: Banks map a $4,275-$5,000 range after bullion’s blockbuster year

ASX 200 forecast for 2026: Rate-hike bets return as strategists split on Australia stocks
Next Story

ASX 200 forecast for 2026: Rate-hike bets return as strategists split on Australia stocks

Go toTop